Table A4.
Pharmacokinetic Parameters of AZD1775 After Administration of Multiple Oral Doses of AZD1775 (twice a day for 2.5 days or once a day for 2 days) in Combination With Gemcitabine in Part 2B
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.